192 related articles for article (PubMed ID: 8186246)
1. Inhibition of cholinesterase activity by tetrahydroaminoacridine and the hemisuccinate esters of tocopherol and cholesterol.
Chelliah J; Smith JD; Fariss MW
Biochim Biophys Acta; 1994 May; 1206(1):17-26. PubMed ID: 8186246
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
3. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
4. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
5. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine.
al-Jafari AA
J Ocul Pharmacol Ther; 1996; 12(4):503-14. PubMed ID: 8951687
[TBL] [Abstract][Full Text] [Related]
6. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds.
Fariss MW; Fortuna MB; Everett CK; Smith JD; Trent DF; Djuric Z
Cancer Res; 1994 Jul; 54(13):3346-51. PubMed ID: 8012947
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease.
Costagli C; Galli A
Biochem Pharmacol; 1998 May; 55(10):1733-7. PubMed ID: 9634011
[TBL] [Abstract][Full Text] [Related]
8. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE.
Wang H; Carlier PR; Ho WL; Wu DC; Lee NT; Li CP; Pang YP; Han YF
Neuroreport; 1999 Mar; 10(4):789-93. PubMed ID: 10208549
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine.
Marquis JK
Biochem Pharmacol; 1990 Sep; 40(5):1071-6. PubMed ID: 2390104
[TBL] [Abstract][Full Text] [Related]
10. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
11. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the effect of tetrahydroaminoacridine on turnover kinetics of camel (Camelus dromedarius) retina acetylcholinesterase.
al-Jafari AA; Kamal MA
Biochem Mol Biol Int; 1996 Aug; 39(5):917-22. PubMed ID: 8866008
[TBL] [Abstract][Full Text] [Related]
13. A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives.
Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
Bioorg Med Chem Lett; 2018 Aug; 28(14):2481-2484. PubMed ID: 29887354
[TBL] [Abstract][Full Text] [Related]
14. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
[TBL] [Abstract][Full Text] [Related]
15. Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers.
Zawadzka A; Lozińska I; Molęda Z; Panasiewicz M; Czarnocki Z
J Pineal Res; 2013 May; 54(4):435-41. PubMed ID: 24325732
[TBL] [Abstract][Full Text] [Related]
16. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
17. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T
Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370
[TBL] [Abstract][Full Text] [Related]
18. In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor.
Gholami A; Minai-Tehrani D; Eriksson LA
Sci Rep; 2023 Jan; 13(1):643. PubMed ID: 36635365
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
20. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation.
Yang Y; Cheng X; Liu W; Chou G; Wang Z; Wang C
J Ethnopharmacol; 2015 Jun; 168():279-86. PubMed ID: 25862961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]